| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.6 |